HFCL has been awarded a substantial ₹2,666.09 crore contract from Rail Vikas Nigam for the BharatNet Phase-III project in Uttar Pradesh, covering telecom equipment supply, optical fibre cable network creation, and 10-year maintenance services. Meanwhile, Rail Vikas Nigam Limited (RVNL) has secured a significant ₹967.92 crore contract from East Coast Railway for bridge construction on an EPC basis for the third and fourth railway lines between Nergundi–Barang and Khurda Road–Vizianagaram on the Bhadrak–Vizianagaram section. These major infrastructure deals demonstrate strong government investment in railway and telecommunications infrastructure projects.
Kirloskar Ferrous Industries emerged as a standout performer, surging 11% after securing an export order worth $13.51 million for the supply of 30,000 metric tonnes of basic grade pig iron on an FOB basis, backed by a sight letter of credit. Anthem Biosciences gained nearly 4% following reports that the promoter group is likely to offload up to a 3.05% stake through block deals, with the floor price set at ₹715 per share. Bosch Home Comfort advanced 2% after promoter Bosch Global Software Technologies announced plans to sell up to a 7.97% stake (21.7 lakh shares) through an offer-for-sale on June 18-19, with a floor price fixed at ₹1,150 per share and a greenshoe option of 0.75%.
Vedanta Power shares rebounded 4% on Wednesday, breaking a two-day losing streak that followed their market debut after the mega demerger. The stock had fallen 2% on the first day and another 2% on Tuesday, but recovered to trade at ₹42 per share on the NSE, crossing its listing price of ₹41.80. The company's market capitalisation currently stands at more than ₹16,126 crore, as reported by ETMarkets. Vedanta Power aims to become one of India's top three private thermal power players by FY33 through a combination of organic expansion and asset turnarounds.
Lupin has launched Azilsartan Medoxomil Tablets in 40mg and 80mg strengths in the US market after receiving approval from the US FDA for its abbreviated new drug application (ANDA). The product is bioequivalent to Edarbi and is indicated for the treatment of hypertension in adults. Lupin is the exclusive first-to-file applicant for the generic version and is eligible for 180 days of generic drug exclusivity in the U.S. market. Lemon Tree Hotels has opened a new property in Sri Ganganagar, Rajasthan, expanding its network in the state to 23 hotels, as reported by Business Standard.
General Insurance Corporation of India (GIC) will be in focus as the government has sold a 5% stake in the company, as reported by ET Now. This divestment is part of the government's broader disinvestment strategy. Gujarat Themis Biosyn has incorporated a step-down subsidiary in Ireland under the name Themis Biosyn. These corporate developments span telecom, infrastructure, pharmaceuticals, financial services, hospitality and power sectors, making them significant drivers for market attention today.
